Utility of atypical antipsychotics in the treatment of resistant unipolar depression (Q37488164)

From Wikidata

Jump to navigation Jump to search

scientific article published on January 2009

edit

Language	Label	Description	Also known as
English	Utility of atypical antipsychotics in the treatment of resistant unipolar depression	scientific article published on January 2009

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19453199

retrieved

20 August 2017

review article

1 reference

stated in

Europe PubMed Central

title

Utility of atypical antipsychotics in the treatment of resistant unipolar depression (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19453199

retrieved

20 August 2017

author name string

Charles DeBattista

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19453199

retrieved

20 August 2017

Jessica Hawkins

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19453199

retrieved

20 August 2017

publication date

1 January 2009

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19453199

retrieved

20 August 2017

published in

CNS Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19453199

retrieved

20 August 2017

volume

23

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19453199

retrieved

20 August 2017

issue

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19453199

retrieved

20 August 2017

page(s)

369-377

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19453199

retrieved

20 August 2017

cites work

Therapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00023210-200923050-00002

retrieved

21 January 2018

Atypical antipsychotics in the treatment of mood disorders

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00023210-200923050-00002

retrieved

21 January 2018

Aripiprazole augmentation in treatment-resistant depression

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.2165%2F00023210-200923050-00002

retrieved

21 January 2018

Definition, assessment, and staging of treatment-resistant refractory major depression: a review of current concepts and methods

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term antidepressant efficacy and safety of olanzapine/fluoxetine combination: a 76-week open-label study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine/fluoxetine combination for treatment-resistant depression: a controlled study of SSRI and nortriptyline resistance.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Psychostimulants for depression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ziprasidone: a novel psychotropic with unique properties

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, fluoxetine, and venlafaxine in treatment-resistant depression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quetiapine augmentation of treatment-resistant depression: a comparison with lithium

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antidepressive effects of traditional and second generation antipsychotics: a review of the clinical data

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Placebo-controlled study of relapse prevention with risperidone augmentation in older patients with resistant depression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quetiapine augmentation in treatment-resistant depression: a naturalistic study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Augmentation and combination strategies for depression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of adjunctive antidepressant therapy with quetiapine on clinical outcome, quality of sleep and daytime motor activity in patients with treatment-resistant depression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjunctive aripiprazole in treatment-resistant bipolar depression.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of risperidone augmentation in patients with treatment-resistant depression: Results of open-label treatment followed by double-blind continuation

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Potential mechanisms of action of atypical antipsychotic medications in treatment-resistant depression and anxiety.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Stimulants in the treatment of depression: a critical overview

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel augmentation strategy for treating resistant major depression

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noradrenergic augmentation of escitalopram response by risperidone: electrophysiologic studies in the rat brain

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of adjunctive ziprasidone in treatment-resistant depression: a randomized, open-label, pilot study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic effects of olanzapine and other antipsychotic agents in combination with fluoxetine on norepinephrine and dopamine release in rat prefrontal cortex

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effectiveness of olanzapine, risperidone, quetiapine, and ziprasidone as augmentation agents in treatment-resistant major depressive disorder

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Comparison of Mirtazapine and Nortriptyline Following Two Consecutive Failed Medication Treatments for Depressed Outpatients: A STAR*D Report

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/19453199

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.2165/00023210-200923050-00002

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19453199

retrieved

20 August 2017

Dimensions Publication ID

1037276660

0 references

PubMed publication ID

19453199

1 reference

stated in

Europe PubMed Central

PubMed publication ID

19453199

retrieved

20 August 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37488164&oldid=2231377896"